We are developing an Artificial Intelligence (AI) technology related medical device for medical institutions and doctors.
We are working towards the realization of a new form of medical care using AI technology to allow doctors to apply the "professional technique" that master physician possess in their examination.
For the Next Step in Medicine
Hippocrates, a founder of medicine, has once said
"Art is long, life is short."
A world where people can begin their training at the cutting edge of medicine. Even in their short lives.
A world where everyone, young and old, can share and nurture the same medical knowledge.
Aillis aims to create such a world, and such medical care.
Development of AI Medical Devices to Support the Diagnosis of Infectious Diseases
As one of the "professional techniques" of a master physician, there is the judging of infectious disease just by looking at patient's pharynx. We are trying to realize a future in which this technique to examine and judge the characteristics of swellings formed in the back of the throat can be generalized by AI technology and be used around the world.
As a first product, we are developing an AI medical device to support the diagnosis of influenza by analyzing patients' pharyngeal images. In addition, we are using the accumulated data to expand our target diseases, starting with influenza, and are moving forward with the development of new businesses.
Our team is consisted of professionals who have worked in the front lines of a wide range of industries, including ministries, consulting firms, IT, and business development, as well as the members from the medical profession and medical healthcare industry.
By bringing together a team of professionals in their respective fields of expertise, we aim to solve various problems that lie in the medical field.
Founder and CEO
Sho Okiyama founded Aillis in 2017.
Prior to the foundation of Aillis, he was the executive officer of a Japanese healthcare startup Medley, inc. Before joining Medley, he worked as an air ambulance doctor and a DMAT (Disaster Medical Assistance Team) member. Earlier in his career, he served as an emergency physician at Japanese Red Cross Medical Center.
He is also the founder of Medical Imaging Working Group in AIST (The National Institute of Advanced Industrial Science and Technology).
He earned his medical degree from the University of Tokyo in 2010.
Co-founder and Chief Strategy Officer
Hiroaki Kato is the Co-founder and CSO of Aillis. He has been our Senior Vice President since April 2019.
Prior to the foundation of Aillis, he started his career as an ophthalmologist at Kyoto Prefectural University of Medicine where he worked for 10 years, and then served as a Deputy Director of Health Policy Bureau in MHLW (Ministry of Health, Labor and Welfare), where he engaged in legal writing and policy making.
He is also a visiting professor at Digital Hollywood University Graduate School, a visiting assistant professor at Chiba University, a clinical associate professor at Tokyo Medical and Dental University and a part-time lecturer at Tohoku University and Yokohama City University. He is an advisor for Medical Innovation Support Office of MHLW and Healthcare Innovation Hub of METI (Ministry of Economy, Trade and Industry) and Nomination Committee at J-Startup. He earned his medical degree from Hamamatsu University School of Medicine.
Atsushi Fukuda has joined Aillis in June 2018 and is the CTO of the company.
Prior to joining Aillis, he served as CTO at Caster, a Japanese HR startup, where he built and scaled an engineering team from 1 to nearly 10. Before joining Caster, he was an engineering manager at SMS Co., Ltd., a website operator regarding elderly care, where he led an engineering team of over 100 members. He also started a new business there.
Earlier in his career, he worked for IBM Research - Tokyo and was involved in a research of model-driven development. He became a technology consultant of embedded systems such as in-vehicles systems.
He earned his master's degree in econometrics from Tohoku University in 2003.
Daichi Tanaka joined Aillis in April 2018 and is the COO of the company.
Prior to joining Aillis, he served in various roles at SMS Co., Ltd., including most recently as Head of Web Department of 'MIMS.com', which is a Singapore-based medical information company SMS has acquired. Before that he led the project of launching a new website about dementia and made it to the most popular website in Japan in the category.
He began his career as a member of sales at Recruit Co.,Ltd.. He also engaged in business development at the Internet Business Promotion Office. He earned his bachelor’s degree from Waseda University.
He is also assigned to Healthcare Industry Expert of Beyond Next Ventures and is the founder and leader of IoMD Working Group in Japan Digital Therapeutics Association.
Masaki started his career as a national government official at Japan’s Ministry of Economy, Trade, and Industry (METI) in April 2014, where he became Head Assistant Director after 1 year and 4 months and then Deputy Director after another 2 years. After supporting healthcare/medical industry expansion at METI, he joined Aillis in November 2018 as Executive Officer and became CCO in September 2019, taking charge of its “outside-the-box” thinking to generate and execute innovative solutions with the national government and many other stakeholders.
He published an academic journal paper “Zen Philosophy of Mindfulness: Nen 念 according to Dōgen's Shōbōgenzō” in a Q1-ranked journal, Religions (ranked #3 on Google Scholar Metrics), and co-authored a case study for Harvard Business School “The Pokémon Company: Evolving into an Everlasting Brand” addressing Japanese management philosophy.
He was selected as Global Shaper by the World Economic Forum and “100 Leaders of Tomorrow (hand-selected)” by the St. Gallen Symposium, and an exclusive community he has served as president for years received the President’s Award from the University of Tokyo for gathering and cultivating outstanding leaders at the university.
Masaki earned his Master of Philosophy from Kyoto University and Bachelor of Arts from the University of Tokyo.
Reserch & Collaboration
Yujiro Maeda joined Aillis in May 2018 as a director. Prior to joining Aillis, he worked for a VC. He also has experience in international business at a pharmaceutical company.
He has been trained at Stanford Biodesign, which provides one of the most structured ways to develop innovative medical devices. He was also involved in establishing Japan Biodesign as a director.
Earlier in his career, he served as an emergency oral surgeon for 7 years.
He is a consultant at Development of Medical Devices through Collaboration between Medicine and Industry in AMED (Japan Agency for Medical Research and Development).
Akiko Yamazaki joined Aillis in April 2018. She holds various rolls in the Corporate Department including accounting, general affairs and labor management.
Prior to joining Aillis, she worked for a healthcare company providing medical information to consumers, where she visited hospitals and clinics nationwide to interview. Before that, she worked for an IT startup and served in various roles such as general affairs and HR. She started her career at the Bank of Japan in 2008.
Takashi Yasumi joined Aillis in July 2018 and is responsible for product design and hardware development of Aillis.
Prior to joining Aillis, he worked at Olympus Corporation as a mechanical engineer from 2015 to 2018. In that role he was involved in research and development of next-generation endoscopes.
He earned his master's degree in engineering from the University of Tokyo in March 2015.
Hiroshi Yoshihara joined Aillis in January 2019 as an AI engineer.
Hiroshi earned his bachelor’s degree and master’s degree in pharmaceutical sciences from the University of Tokyo, where he carried out researches in health technology assessment and health insurance claims data analysis. Currently he is a doctoral student at Kyoto University as well as a researcher at the University of Tokyo.
Hiroshi engaged in development of robot control system in a college robot contest team. He also participated in many domestic and international data science competitions and made good achievements. He has the title of Kaggle Master.
Outside of work, Hiroshi knows four languages and gives lectures about AI and healthcare inside and outside Japan.
Reserch & Collaboration
Memori Fukuda joined Aillis in February 2019. She engages in research and product development from the medical point of view.
Prior to joining Aillis, she worked at the National Hospital Organization Tokyo Medical Center and Keio University Hospital, Department of Cardiology.
She earned her medical degree from Tokyo Women's Medical University. She is a board-certified member of the Japanese Circulation Society, and is also certified as a Japan Medical Association industrial physician.
She is the Public Relations Ambassador of the Japanese Circulation Society, a medical writer (Yahoo!, bouncy, etc.) and a resilience training lecturer.
Kazuto Honda joined Aillis in February 2019.
Over the years, he has been involved in regulatory applications in several medical device manufacturers before joining Aillis. He has also managed the department of regulatory affairs at a major manufacturer.
Alongside, he worked as a member of the industry organization and was involved in various activities such as law revision, establishment of JIS, and formulation of AED advertising guidelines. Since 2016, he has been working as a regulatory consultant, supporting a number of medical device manufacturers.
Product Management / RA / QA
Mizuki Watanabe joined Aillis in March 2019. She is supporting the operation widely.
Before joining Aillis, she worked at Management Support Division of M3 Career Inc., a Japanese healthcare company, and was involved in hospital management from the perspective of human resources.
She worked as a care worker at two nursing homes earlier in her career.
Ken Takahashi joined Aillis in October 2019 as a hardware engineer.
Before joining Aillis, he worked as a mechanical engineer of Yamaha Corporation, where he designed electronic piano keyboard systems. At the same time, he participated in new business proposals.
He engaged in research on nanoimprinting (a microfabrication technology) in the Department of Mechanical Engineering, the University of Tokyo. He earned his master’s degree in March 2015.
His Master's thesis presentation won Dean's Award and the Japan Society of Mechanical Engineers Miura Award.
Masashi Sode joined Aillis in October 2019 as a software engineer. He has been engaged extensively in software and medical AI development.
Before joining Aillis, he has been researching the composite aircraft design using simulation and multi-objective bayesian optimization.
He earned his master’s degree in aerospace engineering from Tohoku University in 2019.
His current research interests focus on augmenting human capabililties through innovative technology. His next goal is to earn Ph.D in biomedical engineering.
Saho Kameyama joined Aillis in December 2019. Prior to joining Aillis, she worked for two IT startups, Advertising and Fintech, and served in various rolls, including business planner, customer service, marketing, growth hacking etc.
She earned her Ph.D. degree from Graduate School of Informatics, Kyoto University. Her fields of research interests are bioacoustics of animals.
Chika Horike joined Aillis in January 2020. She is in charge of PR and communications.
Before joining Aillis, she served in various roles at Medley, a Japanese healthcare startup, from 2015 to 2018, including media planner, editor-in-chief, product manager, etc.
Prior to Medley, she worked as an intrepreneur of a Japanese internet media company GREE, Inc. She was involved in launching a new business about online senior care referral service.
She began her career as an editor at a major publishing company. She has also spent time as a customer service at an educational startup company.
Yuji Ariyasu joined Aillis in August 2020 as an AI engineer.
While working as a web engineer before joining Aillis, he became interested in machine learning and began studying it in July 2019. In May 2020 he won second place in the Kaggle ARC competition.
Takashi Kinouchi joined Aillis in September 2020.
Prior to joining Aillis, he served in various roles at LEOMO, Inc., a Japanese company developing a device for athletes, including a creator of company logos and a project manager of TYPE-S.
Before that, he joined Sony Mobile at 2013 and served as a product planning manager for Xperia Z series smartphones and tablets, and led the development of Z1 to Z5 .
Earlier in his career, he engaged in product planning of Walkman, which is a portable audio player, since 1995 he joined Sony Corporation. During the planning manager era, he won the number one share from Apple, was made into a TV drama, and was selected as the main character.
Wataru Takahashi first joined Aillis in 2018 as a part time AI engineer after he lost his 1 year old son to influenza. He joined full time in October 2020.
Prior to joining Aillis, he was a member of Inaho inc., an AI agriculture startup.
He started his career at Shimadzu corporation in 2007 and was involved in research and development of medical imaging. From 2013 he spent 2 years in Montreal, Canada, where he began to focus on AI. After he came back from Canada to Japan he started to leed AI R&D project in Shimadzu. He has wrote papers on AI and delivered oral presentations at Japanese Association for Medical Artificial Intelligence and The Japanese Society for Regenerative Medicine. In 2018 he also led a co-creation project with an AI startup company and became a member of Kyoto Prefectural University of Medicine.
He earned his master’s degree in quantum science and energy engineering from Tohoku University.
Mari Kurashima joined Aillis in December 2020. Prior to joining Aillis, she worked at CARADA medica Inc., where she served as a product owner of telemedicine service and was involved in requirements definition, testing design, and release management.
Earlier in her career, she served as an application engineer at Simplex and worked on the planning and development of FX trading applications. Having had several relatives suffered the aftereffects of brain diseases, she shifted to the healthcare industry.
Koichiro Okada joined Aillis in April 2021 and is currently engaging in hardware development. Prior to joining Aillis he worked at Medicaroid, Inc, where he was involved in the development of cleaning and sterilization of robotic forceps in the development project of Japan's first surgical support robot "hinotori", establishing the cleaning and sterilization method from scratch and commercializing the cleaning and sterilization device.
He began his career at Olympus Corporation, where he engaged in the development of new products for endoscope cleaning and disinfection systems for about 7 years, with extensive experience from upstream to downstream of the development process, focusing on design and verification.
Dai Okita joined Aillis in June 2021. Prior to joining Aillis, he worked at Tecom Co. as Director and Vice President, where he was in charge of PMI, development of content such as reference books, question books, and web courses for medical students and other students preparing for national medical certification exams, and IT and legal affairs.
He has graduated from International Christian University in 2008, and experienced his first career at SIer where he worked in legal affairs and corporate planning. He has then Joined M3, Inc. in 2012 where he was in charge of member acquisition, promotion of use, and business alliances for m3.com, a web service for doctors.
Mayu Kuroki joined Aillis in October 2021.
She began her career as a business strategy consultant at Bain & Company where she has been involved in company-wide strategic plannings and new business plannings in wide range of fields.
Later, at Nagoya University, she was involved in the management of a large-scale industry-academia collaboration project with other universities. Simultaneously, she became an independent consultant, providing supports to start-up companies.
Born in Niigata Prefecture. After graduating from a local public junior and senior high school, he entered the School of Medicine at University of Tokyo, from his shock by the gap of "Normal state" among different regions. While in school, he was immersed in supporting high school students in rural areas and launching various medical education projects. After graduation, he was trained by a community medical worker in Nagano Prefecture. Experiencing pediatric training at the University of Tokyo Hospital, he worked as a pediatrician at a tertiary emergency hospital in Fukushima Prefecture, where he encountered the largest hospital cluster in the Tohoku region. He joined Aillis Inc. in 2022.
After graduating from the Graduate School of Medicine at Osaka University in 2016, she worked at a hospital as a clinical laboratory technician. She was responsible for all aspects of specimen testing.
After that, she joined the Japan Organ Transplant Network. As a transplant coordinator, she was involved in coordinating the entire process from organ donation to transplantation, including providing necessary explanations to families who are considering organ donation and coordinating between professionals and multiple facilities.
In October 2021, she joined Aillis Inc.
After passing the CPA exam while on leave from Nagoya University in 2008, he joined KPMG Azusa & Co. At KPMG, he worked for four years on accounting audits and IFRS implementation support for global companies, including companies preparing to list on overseas securities markets. While working at the audit firm, he participated in the Japan Overseas Cooperation Volunteers (JOCV) in Senegal and was transferred to KPMG in Kenya.
After that, he worked for an educational venture company at Philippines as a business administration manager, where he was responsible for improving the financial reporting system, strengthening the internal control system, and managing cash flow with a view to listing.
In November 2021, he joined Aillis Inc., where he is mainly in charge of the accounting area and preparations for listing.
He is engaged in clinical research start-up and project management at multiple CROs.In addition to research secretariat work related to the preparation of documents and applications necessary for the launch of clinical research, he was also involved in data management work.
He joined Aillis Inc. in February 2022 as a project manager for clinical research and clinical trials.
After graduating from Waseda University, he experienced 8 years of contact center management at a major telemarketing company that operates contact centers. After this experience, he joined IBM Business Consulting Services Corporation (now IBM Japan, Ltd.) as a consultant in the CRM area. (now IBM Japan, Ltd.). As a consultant in the CRM field, he was mainly involved in contact center-related projects, and handled many projects from upstream to downstream, including basic concept development, new construction, and business process improvement. Later, he changed his career to work for Fuji Xerox Co., Ltd. and Rakuten Mobile, Inc. where he was in charge of strategic planning for the contact center of their services.
He joined Aillis Inc. in February 2022.
After graduating from the School of Law at Keio University and the Graduate School of Law at Kyoto University, he was registered as an attorney of law in 2010. At Jinho Law office, he was engaged in medical legal affairs (in the fields of medical affairs at university hospitals, labor disputes, crisis management, responses for misconducts, and clinical research), pharmaceutical legal affairs, and digital health legal affairs. In 2022, he joined Aillis Inc.
Besides working at Aillis, Inc., he is a co-representative of Suwa & Asano Law Office, an external member of Research Ethics Committee at Japanese Red Cross College of Nursing, The Japanese Society for Breastfeeding Research and Tokiwa Group Yochomachi Clinic, an auditor of Medical Corporation Sukoyaka, a part-time lecturer at a nursing school at Yokosuka city, and a supervisor of the Pharmaceutical Affairs Act. He is currently a Ph.D. student at the Graduate School of Medicine at Juntendo University where he majors in hospital management.
After graduating from the department of Sociology at Rikkyo University, he was engaged in developing web media at a startup company. Subsequently, he began his career as an independent software engineer, and committed to develop services such as crowdfunding and cloud billing services.
In March 2022, he joined Aillis, Inc.
In 2006, he joined TEPCO where he was in charge of shareholder meetings and investor relations in the General Affairs Department at the head office. Later, he was engaged in corporate governance at Honda Motor Co., Ltd. and at Mitsubishi UFJ Trust and Banking Corporation.
After working as a head of the IPO preparation office and corporate governance at Freee, he joined Aillis Inc. in December 2021 where he is mainly in charge of building governance and preparations for IPO. Born and raised in Yamaguchi prefecture, at home, he is a father of four children.
After graduating from Polytechnic University in 2009, he worked for three companies so far. He was mainly engaged as a software developer of video machine system for the last 14 years. He got interested in medical devices after he found out about his refractory low back pain. In July 2022, he joined Aillis, Inc.
After graduating from Tokyo Institute of Technology in 1995, he joined Sony Corporation. He had been engaged in the development of the magneto-optical disc system, OLED display, and LCD for digital cameras. He moved to Witswell Consulting & Solutions Inc. where he was involved in a medical device development project for two years. In 2008, he joined Baxter and worked on the development and commercialization of the medical device for peritoneal dialysis as an electrical and microbiological engineer. He joined Aillis, Inc in 2021 as a business consignment and officially joined in September 2022.
We are currently searching for a new member who can work with us.
2024/02/21Our CEO, Sho Okiyama, was interviewed by MARR.
2024/02/14Aillis appeared in BS-TBS.
2024/02/07Our CEO, Sho Okiyama, gave a presentation at Japan Agency for Medical Research and Development.
2024/02/06Our product "nodoca" appeared in NHK.
2024/02/06Our product "nodoca" appeared in NHK.
2024/02/05Our CEO, Sho Okiyama, contributed to Igaku-Shoin.